OLVIG
MIST icon

Oliver Lagore Vanvalin Investment Group’s Milestone Pharmaceuticals MIST Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$80 Buy
+100
New +$133 ﹤0.01% 642
2024
Q4 		$236 Hold
100
– – ﹤0.01% 649
2024
Q3 		$152 Hold
100
– – ﹤0.01% 655
2024
Q2 		$132 Hold
100
– – ﹤0.01% 703
2024
Q1 		$179 Hold
100
– – ﹤0.01% 703
2023
Q4 		$167 Hold
100
– – ﹤0.01% 727
2023
Q3 		$310 Buy
+100
New +$311 ﹤0.01% 787

Other funds holding MIST

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's MIST Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2025: 100 shares worth $80. The stake represents ﹤0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in MIST as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in MIST in Q3 2023 and has held it in 7 quarters since. The position peaked at $310 in Q3 2023. 43 funds tracked by Wall St. Rank hold MIST as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 100 shares of Milestone Pharmaceuticals worth $80 as of Q2 2025.
  • Milestone Pharmaceuticals was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Milestone Pharmaceuticals made up ﹤0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #642 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Milestone Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Milestone Pharmaceuticals position peaked at $310 in Q3 2023.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.